PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
Data sourced from IRS 990-PF public filings
Funds research in the field of cancer immunotherapy, primarily supporting universities and research institutes located in the United States.
Grants (Last Year)
$0
Total Grants on File
27
Recipients Funded
16
Giving History
| Year | Total Granted | Grants Made | Avg Grant |
|---|---|---|---|
| 2023 | $13,967,003 | 12 | $1,163,917 |
| 2021 | $9,050,382 | 15 | $603,359 |
Top Grant Recipients
PHILADELPHIA, PA
REDWOOD CITY, CA
REDWOOD CITY, CA
SAN FRANCISCO, CA
BOSTON, MA
NEW YORK, NY
SAINT LOUIS, MO
SAN FRANCISCO, CA
SAN FRANCISCO, CA
LOS ANGELES, CA
Showing top 10 of 27 grants on file.
Officers & Trustees
From 2023 IRS 990-PF filing (data available for 2 filing years)
UTE DUGAN MD
CHIEF MEDICAL OFFICER
JOHN CONNOLLY PHD
CHIEF SCIENTIFIC OFFICER
KEVIN MARKS
CHIEF LEGAL OFFICER
TARAK MODY
CHIEF BUSINESS OFFICER
SHANE CORCORAN
SENIOR VP, STRAT. OPS. & COMMS
SARA COBLIN
SR VP FINANCE & ADMIN.
MARKO SPASIC
SR MEDICAL DIR, HEAD OF MED
CHRIS CABANSKI
SR DIR, NETWORK CLINICAL RES.
SEAN N PARKER
CHAIR OF THE BOARD & DIRECTOR
MICHAEL POLANSKY
EXECUTIVE VP & DIRECTOR
Showing 10 of 26 officers and trustees.
IRS Filing History
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY has IRS 990-PF filings on record for 2 years, spanning 2021 to 2023.
Frequently Asked Questions
Other Foundations in California
Unlock Full Foundation Data
Sign up for free to access the complete grant history, financial trends, key personnel, smart matching, and export tools.